Phase I trial of Acura Pharmaceuticals' abuse-resistant hydromorphone (LTX-04)
Phase of Trial: Phase I
Latest Information Update: 14 Dec 2016
At a glance
- Drugs Hydromorphone (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Acura Pharmaceuticals
- 14 Dec 2016 Results published in the Acura Pharmaceuticals Media Release.
- 11 Jul 2016 According to an Acura Pharmaceuticals media release. the company will present detailed analysis of data from this trial in a conference call and webcast on July 14, 2016.
- 08 Jun 2016 Topline results from cohort 2 of this trial published in an Acura Pharmaceuticals media release.